Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02029040 · ClinicalTrials.gov registry record · NA
Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT02029040 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 52 participants.
The verdict
NCT02029040, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, controlled trial in the Pediatric Emergency Department. The primary objective is to determine whether nebulized 3% hypertonic saline is more effective than nebulized 0.9% saline in the treatment of bronchiolitis in the emergency department.
Interventions
- DRUG 3% Hypertonic Saline
- DRUG 0.9 % normal saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02029040
The ClinicalTrials.gov registry entry for NCT02029040 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 3% Hypertonic Saline is the first listed.
NCT02029040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02029040 about?
NCT02029040 is a clinical study titled "Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis". This is a randomized, double-blind, controlled trial in the Pediatric Emergency Department. The primary objective is to determine whether nebulized 3% hypertonic saline is more effective than nebulized 0.9% saline in the treatment of bronchiolitis in the emergency department.
What is the current status of trial NCT02029040?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2013-12. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02029040?
The interventions under investigation include: 3% Hypertonic Saline (DRUG), 0.9 % normal saline (DRUG).
Who is sponsoring clinical trial NCT02029040?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.